Carrier Screening for Spinal Muscular Atrophy (SMA) in 107,611 Pregnant Women during the Period 2005–2009: A Prospective Population-Based Cohort Study
2011

Carrier Screening for Spinal Muscular Atrophy in Pregnant Women

Sample size: 107611 publication Evidence: high

Author Information

Author(s): Su Yi-Ning, Hung Chia-Cheng, Lin Shin-Yu, Chen Fang-Yi, Chern Jimmy P. S., Tsai Chris, Chang Tai-Sheng, Yang Chih-Chao, Li Hung, Ho Hong-Nerng, Lee Chien-Nan

Primary Institution: National Taiwan University College of Medicine

Hypothesis

Routine carrier screening for spinal muscular atrophy (SMA) is feasible and beneficial in the general population.

Conclusion

The study found that SMA carrier screening can effectively identify carriers and provide genetic counseling to reduce the risk of having affected children.

Supporting Evidence

  • 2,262 SMA carriers were identified among the 107,611 pregnant women screened.
  • The carrier rate was approximately 1 in 48 (2.10%).
  • The negative predictive value of the screening method was 99.87%.
  • Prenatal diagnostic testing was performed in 43 women, with SMA diagnosed in 12 fetuses.

Takeaway

This study tested a lot of pregnant women to see if they carry a gene for a disease called spinal muscular atrophy, which can make babies very sick. They found many carriers and helped families understand their risks.

Methodology

A three-stage screening program was used to test pregnant women for SMA heterozygosity, followed by testing of partners if the mother was a carrier.

Limitations

The study may not identify all carriers, particularly those with two copies of SMN1 on one chromosome, and there is a risk of false negatives due to de novo mutations.

Participant Demographics

The study included 107,611 pregnant women from 25 counties in Taiwan, primarily Taiwanese, with a majority aged 20-39.

Digital Object Identifier (DOI)

10.1371/journal.pone.0017067

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication